Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Mukesh Ambani-led Reliance Industries posted a 16% YoY jump in Q2 profit after tax, while revenue saw a 10% growth. Its PAT ...

Digital bank Revolut has still not moved forward with a complete UK banking license, partly due to regulatory shortcomings : ...

Q3 2025 Earnings Call Transcript October 16, 2025 CSX Corporation beats earnings expectations. Reported EPS is $0.44, expectations were $0.4241. Operator: Ladies and gentlemen, thank you for standing ...

Reliance Q2 FY26 profit rises 14.3% to Rs 22,092 crore as revenue grows nearly 10% YoY, driven by O2C, Jio, and Retail businesses.

First BanCorp will announce its third-quarter financial results before market opening on Thursday, October 23, 2025. Management will subsequently host a conference call at 10:00 AM Eastern Time, ...

Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise after chemotherapy can improve cancer-related cognitive impairment. However, ...

Market experts have suggested Infosys and TCS for long-term investment due to their resilience and profitability ...

A man from Franklin is accused of driving in the wrong lane when his truck slammed into a car carrying a family of four.

I played the Black Ops 7 beta, and while it may not reinvent the killstreak, it doubles down on what fans actually love.

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...